{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-027707","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.237387+00:00","generated_at":"2026-05-26T03:38:51.126069+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Revolution Medicines Q4 2024 net loss $194.6M, cash $2.3B; Phase 3 PDAC enrollment target 2025","bullets":["Q4 net loss $194.6M vs $161.5M YoY; full year net loss $600.1M vs $436.4M.","Cash and securities $2.3B at Dec 31, 2024, up from $1.9B; $823M net raised in Dec 2024 public offering.","2025 GAAP net loss guidance $840M-$900M; cash runway expected into H2 2027.","Expects to complete enrollment in Phase 3 RASolute 302 (PDAC) in 2025 for data readout in 2026; Phase 3 RASolve 301 (NSCLC) now activating sites.","Plans to initiate two additional registrational trials for daraxonrasib in earlier-line PDAC in H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-027707","json":"https://secwatch.observer/filing/0000950170-25-027707.json","markdown":"https://secwatch.observer/filing/0000950170-25-027707.md","text":"https://secwatch.observer/filing/0000950170-25-027707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000095017025027707/0000950170-25-027707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000095017025027707/rvmd-20250226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:38:51.126069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}